Literature DB >> 21840489

Coexpression of normally incompatible developmental pathways in retinoblastoma genesis.

Justina McEvoy1, Jacqueline Flores-Otero, Jiakun Zhang, Katie Nemeth, Rachel Brennan, Cori Bradley, Fred Krafcik, Carlos Rodriguez-Galindo, Matthew Wilson, Shunbin Xiong, Guillermina Lozano, Julien Sage, Ligia Fu, Lotfi Louhibi, Jeff Trimarchi, Amar Pani, Richard Smeyne, Dianna Johnson, Michael A Dyer.   

Abstract

It is widely believed that the molecular and cellular features of a tumor reflect its cell of origin and can thus provide clues about treatment targets. The retinoblastoma cell of origin has been debated for over a century. Here, we report that human and mouse retinoblastomas have molecular, cellular, and neurochemical features of multiple cell classes, principally amacrine/horizontal interneurons, retinal progenitor cells, and photoreceptors. Importantly, single-cell gene expression array analysis showed that these multiple cell type-specific developmental programs are coexpressed in individual retinoblastoma cells, which creates a progenitor/neuronal hybrid cell. Furthermore, neurotransmitter receptors, transporters, and biosynthetic enzymes are expressed in human retinoblastoma, and targeted disruption of these pathways reduces retinoblastoma growth in vivo and in vitro.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21840489      PMCID: PMC3551581          DOI: 10.1016/j.ccr.2011.07.005

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  43 in total

1.  Large-cell medulloblastoma with arrestin-like protein expression.

Authors:  S Vincent; M Mirshari; C Nicolas; C Adenis; P Dhellemmes; G Soto Ares; C A Maurage; M C Baranzelli; F Giangaspero; M M Ruchoux
Journal:  Clin Neuropathol       Date:  2003 Jan-Feb       Impact factor: 1.368

2.  Single-cell transcriptional analysis of neuronal progenitors.

Authors:  Ian Tietjen; Jason M Rihel; Yanxiang Cao; Georgy Koentges; Lisa Zakhary; Catherine Dulac
Journal:  Neuron       Date:  2003-04-24       Impact factor: 17.173

3.  Representation is faithfully preserved in global cDNA amplified exponentially from sub-picogram quantities of mRNA.

Authors:  Norman N Iscove; Mary Barbara; Marie Gu; Meredith Gibson; Carolyn Modi; Neil Winegarden
Journal:  Nat Biotechnol       Date:  2002-08-12       Impact factor: 54.908

4.  Spontaneous tumorigenesis in mice overexpressing the p53-negative regulator Mdm4.

Authors:  Shunbin Xiong; Vinod Pant; Young-Ah Suh; Carolyn S Van Pelt; Yongxing Wang; Yasmine A Valentin-Vega; Sean M Post; Guillermina Lozano
Journal:  Cancer Res       Date:  2010-08-24       Impact factor: 12.701

5.  Characteristics of an established cell line of retinoblastoma.

Authors:  T W Reid; D M Albert; A S Rabson; P Russell; J Craft; E W Chu; T S Tralka; J L Wilcox
Journal:  J Natl Cancer Inst       Date:  1974-08       Impact factor: 13.506

6.  The nature of retinoblastoma. I. Photoreceptor differentiation: a clinical and histopathologic study.

Authors:  M O Ts'o; L E Zimmerman; B S Fine
Journal:  Am J Ophthalmol       Date:  1970-03       Impact factor: 5.258

7.  The nature of retinoblastoma. II. Photoreceptor differentiation: an electron microscopic study.

Authors:  M O Ts'o; B S Fine; L E Zimmerman
Journal:  Am J Ophthalmol       Date:  1970-03       Impact factor: 5.258

8.  Characterization of a new continuous cell line derived from a human retinoblastoma.

Authors:  R C McFall; T W Sery; M Makadon
Journal:  Cancer Res       Date:  1977-04       Impact factor: 12.701

9.  Synapse formation in retinoblastoma tumours.

Authors:  D H Dickson; M S Ramsey; J G Tonus
Journal:  Br J Ophthalmol       Date:  1976-05       Impact factor: 4.638

10.  Genetic analysis of the homeodomain transcription factor Chx10 in the retina using a novel multifunctional BAC transgenic mouse reporter.

Authors:  Sheldon Rowan; Constance L Cepko
Journal:  Dev Biol       Date:  2004-07-15       Impact factor: 3.582

View more
  67 in total

1.  Targeting the p53 pathway in retinoblastoma with subconjunctival Nutlin-3a.

Authors:  Rachel C Brennan; Sara Federico; Cori Bradley; Jiakun Zhang; Jacqueline Flores-Otero; Matthew Wilson; Clinton Stewart; Fangyi Zhu; Kip Guy; Michael A Dyer
Journal:  Cancer Res       Date:  2011-04-22       Impact factor: 12.701

2.  Single-cell profiling of developing and mature retinal neurons.

Authors:  Jillian J Goetz; Jeffrey M Trimarchi
Journal:  J Vis Exp       Date:  2012-04-19       Impact factor: 1.355

Review 3.  The retinoblastoma tumor suppressor and stem cell biology.

Authors:  Julien Sage
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

Review 4.  Retinoblastoma, the visible CNS tumor: A review.

Authors:  Helen Dimaras; Timothy W Corson
Journal:  J Neurosci Res       Date:  2018-01-03       Impact factor: 4.164

5.  Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.

Authors:  Hans E Grossniklaus
Journal:  Am J Ophthalmol       Date:  2014-07-24       Impact factor: 5.258

6.  Cancer: The origin of human retinoblastoma.

Authors:  Rod Bremner; Julien Sage
Journal:  Nature       Date:  2014-09-24       Impact factor: 49.962

7.  Identification of microRNA-mRNA regulatory networks and pathways related to retinoblastoma across human and mouse.

Authors:  Rui Tian; He Zou; Lu-Fei Wang; Mei-Jiao Song; Lu Liu; Hui Zhang
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

Review 8.  Transgenic Models in Retinoblastoma Research.

Authors:  Rohini M Nair; Geeta K Vemuganti
Journal:  Ocul Oncol Pathol       Date:  2015-04-09

Review 9.  Retinoblastoma.

Authors:  Helen Dimaras; Timothy W Corson; David Cobrinik; Abby White; Junyang Zhao; Francis L Munier; David H Abramson; Carol L Shields; Guillermo L Chantada; Festus Njuguna; Brenda L Gallie
Journal:  Nat Rev Dis Primers       Date:  2015-08-27       Impact factor: 52.329

10.  Role of RB1 in human embryonic stem cell-derived retinal organoids.

Authors:  Canbin Zheng; Jay W Schneider; Jenny Hsieh
Journal:  Dev Biol       Date:  2020-03-19       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.